Data / New clinical trials / United States
New clinical trials in United States: 18,242 since Nov 2024
The full list. New clinical trials with a site in United States: 18,242 rows for $262.42, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 712 rows a month. The new rows come each week by email, $35.60 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/united-states, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
18,242 clinical studies with a site in United States were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 5,727 have an industry sponsor and 12,708 are recruiting or about to. The newest, NCT07926997, was posted on November 9, 2026: Pharmacokinetics of Oral Zoliflodacin 3 g in Healthy Lactating Women (Global Antibiotics Research and Development Partnership).
The request: Every new clinical trial with a site in United States, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 18,242New trials
- 5,727Industry sponsored
- 12,708Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 18,242, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07926997 | Pharmacokinetics of Oral Zoliflodacin 3 g in Healthy Lactating Women | Global Antibiotics Research and Development Partnership | Phase 4 | Not yet recruiting | Lactation | 10 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926984 | Power of Play Study | University of Minnesota | Not applicable | Not yet recruiting | Hospitalization in Children | 90 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926945 | Effects of nVNS on Stress Reactivity in IBS | University of California, Los Angeles | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 200 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926906 | Removing the Planning Tumor Volume From Radiation Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma | City of Hope Medical Center | Not applicable | Not yet recruiting | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated... | 30 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926893 | Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary Syndrome | City of Hope Medical Center | Phase 1 | Not yet recruiting | Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome, Recurrent Transformed Mycosis Fungoides, Refractory Mycosis... | 14 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926880 | Letter-Writing Add-On to Brief Motivational Intervention for Alcohol Use | Wayne State University | Not applicable | Not yet recruiting | Heavy Drinking, Alcohol Drinking | 86 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926594 | Effectiveness Study of TRYPTYR in Dry Eye Disease | Scott & Christie and Associates, PC | Observational | Recruiting | Dry Eye Disease | 100 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926568 | Healing Trauma Plus | Envisioning Justice Solutions, Inc | Not applicable | Completed | Trauma-related PTSD, Anxiety and Distress, Depression | 256 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926425 | Retrospective Evaluation of Visual Outcomes, Safety and Enhancement Rates Following Wavefront-Guided LASIK Using a 10 MHz Elita Femtosecond... | CB Consulting | Observational | Recruiting | Visual Acuity | 175 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926347 | Functional Reorganization and Recovery of the Language and Domain-general Multiple Demand Systems in Aphasia | Boston University Charles River Campus | Not applicable | Not yet recruiting | Aphasia | 100 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926334 | A Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D Mutation | Boehringer Ingelheim | Phase 1 | Not yet recruiting | Advanced or Metastatic Solid Tumors With KRAS G12D Mutation | 200 | Australia, Japan, South Korea, Spain, United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | Belgium, Finland, Germany, Japan, Mexico, South Korea, Spain, United States | clinicaltrials.gov |
| November 9, 2026 | NCT07926243 | "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South) | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Multiple Chronic Conditions, Shared Decision-making | 44 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925983 | A Study to Assess How Intravenous and Subcutaneous Administrations of Trosunilimab Move Through the Body of Healthy Adult Participants | AbbVie | Phase 1 | Recruiting | Healthy Volunteer | 60 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925879 | Social Media Perceptions Among Young Adults With Cancer - Aim 1: Interviews | UNC Lineberger Comprehensive Cancer Center | Observational | Completed | Cancer, Cancer Survivors | 33 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925801 | Relacorilant in Patients With Poorly Controlled Type 2 Diabetes and Autonomous Cortisol Secretion | The University of Texas Health Science Center at San Antonio | Phase 1/2 | Not yet recruiting | Type 2 Diabetes, Hypercortisolism | 34 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925710 | Osteoarthritis Care Tools for Primary Care Providers in Family Medicine and Geriatrics Clinics | University of North Carolina, Chapel Hill | Not applicable | Not yet recruiting | Arthritis, Osteo Arthritis Knee and Hip | 205 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925580 | Trial of Self-Applied Transcutaneous Auricular Vagus Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy | University of Miami | Not applicable | Not yet recruiting | Chemotherapy Induced Peripheral Neuropathy (CIPN) | 55 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925450 | Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease | Weill Medical College of Cornell University | Phase 4 | Recruiting | Crohn's Disease, Iron Deficiency Anemia | 150 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925333 | Lifileucel (TIL) Therapy After PD-1 Blockade Failure in Kidney Cancer | Beth Israel Deaconess Medical Center | Phase 2 | Not yet recruiting | Kidney Cancers, Renal Cell Carcinoma (Kidney Cancer) | 10 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925268 | Study of Ifinatamab Deruxtecan in De Novo or Treatment-Emergent Neuroendocrine Prostate Cancer | Rahul Aggarwal | Phase 2 | Not yet recruiting | Neuroendocrine Prostate Cancer (NEPC), Metastatic Prostate Adenocarcinoma, Prostate Cancer | 30 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925255 | Daily, Weekly, or Event-driven Doxycycline for STI Prevention Among Men Who Have Sex With Men (MSM) Engaging in Chemsex: The DOSE... | University of California, Los Angeles | Phase 4 | Not yet recruiting | Gonorrhea, Chlamydia, Syphilis | 300 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925242 | FAPI PET in Systemic Sclerosis Interstitial Lung Disease | University of California, Los Angeles | Phase 2 | Not yet recruiting | Systemic Sclerosis (SSc), Scleroderma, Interstitial Lung Disease With Systemic Sclerosis | 120 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07925034 | PREFIX FEASIBILITY Study - PRojection & Safety Evaluation of the FIXNip Nipple Reconstruction Implant | FixNip Ltd | Not applicable | Recruiting | Breast Reconstruction After Mastectomy | 5 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924930 | A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function | Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company | Phase 1 | Not yet recruiting | Renal Insufficiency, Healthy Participant | 32 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924904 | Mindfulness Meditation to Reduce Cognitive Load | University of South Carolina | Not applicable | Not yet recruiting | Test Anxiety, Stress, Psychological, Cognitive Aging | 60 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924852 | Neuromodulation of Motivation and Reward Oscillations | Florida State University | Not applicable | Recruiting | Cannabis Use Disorder, Major Depression, Anhedonia, Transcranial Alternating Current Stimulation | 54 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924839 | PM2.5 Exposure, Obesity, and Cardiovascular Health | Michigan State University | Not applicable | Recruiting | Cardiovascular (CV) Risk | 20 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924800 | Improving Labor Management for Patients With Severe Obesity Using Abdominal Pannus Retraction | Medical College of Wisconsin | Not applicable | Not yet recruiting | Birth Length, Severe Obesity | 100 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924761 | A Study to Investigate the Effect of Injection Site and Ethnicity on KAI-4729 Pharmacokinetics in Non-Asian and Asian Participants Living... | Kailera | Phase 1 | Not yet recruiting | Overweight or Obesity | 60 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924735 | Opioid Sparing Cognitive Behavioral Therapy (CBT) Intervention to Manage Acute Pain, and Pain Catastrophizing in Surgical Patients | Mayo Clinic | Not applicable | Active not recruiting | Post-surgical Pain | 80 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924605 | PSMA PET/MRI for Predicting and Detecting Prostate Cancer | University of Wisconsin, Madison | Phase 2 | Not yet recruiting | Prostate Cancer, High-Risk Localized Prostate Cancer, Locally Advanced Prostate Cancer, Low-Risk Prostate Cancer... | 120 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924241 | Medically Tailored Meals to Improve Cancer Outcomes | Washington University School of Medicine | Not applicable | Not yet recruiting | Cancer, Healthy Eating | 90 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07924215 | PureSee EDOF Versus ZCB00 Monofocal IOLs in Mild-to-Moderate Glaucoma | Mann Eye Institute | Observational | Not yet recruiting | Primary Open-Angle Glaucoma | 100 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07923981 | A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without Inhibitors | Pfizer | Phase 3 | Recruiting | Hemophilia A or B | 95 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07923903 | Research Participant Registry "Hopkins Opportunities for Participant Engagement" | Johns Hopkins University | Observational | Not yet recruiting | Research Participation, Recruitment, Engagement, Research Awareness | 1,000 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07923877 | Induction Chemoimmunotherapy to Prevent Laryngectomy in Advanced Laryngeal Cancer and Hypopharyngeal Cancer | Mayo Clinic | Phase 2 | Not yet recruiting | Advanced Laryngeal Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Stage III Laryngeal Cancer AJCC v8... | 50 | United States | clinicaltrials.gov |
| November 9, 2026 | NCT07923864 | An Efficacy Trial of The Toolkit for Optimal Recovery After Concussion | Massachusetts General Hospital | Not applicable | Not yet recruiting | Concussion (Diagnosis), Mild Traumatic Brain Injury, Post Concussion Symptoms, Anxiety | 260 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923760 | Supplemental Oxygen for Sleep-Disordered Breathing in Adults With Chronic Opioid Use. | University of California, San Diego | Phase 2 | Not yet recruiting | Sleep-disordered Breathing, Chronic Opioid Use | 62 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923734 | Study of Electrocardiogram (ECG) Safety of Sezaby in Neonatal Seizures | Sun Pharma Advanced Research Company Limited | Phase 4 | Not yet recruiting | Neonatal Seizure | 45 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923721 | Comprehensive Opioid Management and Breathing During Sleep | University of California, San Diego | Not applicable | Not yet recruiting | Sleep-Disordered Breathing, Chronic Opioid Use | 68 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923630 | Validation & Intervention Testing for Aging, Longevity and Healthspan | The University of Texas Health Science Center at San Antonio | Phase 2 | Not yet recruiting | Aging, Functional Decline | 1,200 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923487 | Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury | Personalized Stem Cells, Inc. | Phase 1 | Enrolling by invitation | Mild Traumatic Brain Injury | 10 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923461 | SERENE Low-Intensity Focused Ultrasound for Cognitive Control | University of Minnesota | Not applicable | Not yet recruiting | Suicidal Ideation, Cognitive Control, Neurocognitive Function | 100 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923370 | Facial Expression Awareness Training to Understand and Recognize Emotions | Children's Hospital of Philadelphia | Not applicable | Recruiting | Survivors of Pediatric Brain Tumors, Pediatric Cancer | 40 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923201 | Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing... | Casa Colina Hospital and Centers for Healthcare | Not applicable | Not yet recruiting | Stroke, Parkinson's Disease (PD), Spinal Cord Injury, Multiple Sclerosis, Orthopedic Injury | 20 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923045 | A Phase 1/2, Single-Dose, Multicenter, Dose Escalation, Clinical Trial to Evaluate the Safety and Efficacy of MR-146: An Open-Label Part 1... | Viatris Inc. | Phase 1/2 | Recruiting | Neurotrophic Keratopathy | 18 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07923032 | Low-Intensity Focused Ultrasound for Gambling Disorder | University of Virginia | Not applicable | Not yet recruiting | Gambling Disorder, Gambling Addiction, Gambling Problem, Gambling | 54 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922876 | Study of Psychoeducation and Reading for Kids (SPARK) | State University of New York - Upstate Medical University | Not applicable | Not yet recruiting | Reading Difficulties, Behavioral Problems, Emotional Problems | 40 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922785 | Stair Biomechanics and Vibration Study After ACLR | University of North Carolina, Chapel Hill | Not applicable | Not yet recruiting | Anterior Cruciate Ligament Reconstruction (ACLR), Anterior Cruciate Ligament Injury | 52 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922733 | EXPANDED-ACCESS PROGRAM FOR THE TREATMENT OF CHRONIC HEPATITIS D WITH BRELOVITUG | Mirum Pharmaceuticals, Inc. | Not applicable | Available | Chronic Hepatitis, Delta Virus | Not listed | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922590 | A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation | Medical University of South Carolina | Not applicable | Not yet recruiting | Alcohol Use Disorder (AUD), Suicide Ideation | 80 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922460 | Anti-VEGF Versus Prompt Laser or Observation for Proliferative Sickle Cell Retinopathy (ALPS) | University of Illinois Chicago | Phase 3 | Not yet recruiting | Proliferative Sickle Cell Retinopathy | 50 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922382 | Integrated Attachment Theory | Boston University Charles River Campus | Not applicable | Not yet recruiting | Attachment Disorder | 24 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922239 | Substance Use and Media Preferences | University of Colorado, Denver | Not applicable | Not yet recruiting | Substance Use Behavior, Cannabis Intoxication, Alcohol Intoxication | 312 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922200 | Biomarkers of Paired VNS | MGH Institute of Health Professions | Not applicable | Recruiting | Stroke, Ischemic | 50 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922187 | Speech Recognition With Hearing Enhancement | Meta Platforms Technologies LLC | Not applicable | Completed | Hearing | 43 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07922122 | Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI | TryAbility LLC | Not applicable | Recruiting | Spinal Cord Injuries | 8 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07921563 | The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity | Dartmouth-Hitchcock Medical Center | Not applicable | Not yet recruiting | Osteoarthritis of the Knee | 50 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07921459 | Mechanisms of Instrument-Assisted Soft Tissue Manipulation (IASTM) Force Dose-Response Effects in the Calf-Foot Region | Indiana University | Not applicable | Not yet recruiting | Limited Ankle Dorsiflexion Due to Calf Muscle Tightness | 40 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07921342 | An Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care | Brigham and Women's Hospital | Not applicable | Not yet recruiting | Chronic Kidney Diseases | 216 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07920952 | Effects of Ad Libitum Ultra-Processed Diet on Brain Dopamine in Humans | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Not applicable | Not yet recruiting | Healthy Volunteers | 140 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07920900 | PRP for Sexual Function | Icahn School of Medicine at Mount Sinai | Not applicable | Recruiting | Female Sexual Dysfunction, Sexual Dysfunction, Physiological | 60 | United States | clinicaltrials.gov |
| November 6, 2026 | NCT07920887 | A Study of Bimagrumab in Participants With HFpEF | Eli Lilly and Company | Phase 2 | Not yet recruiting | Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction, Heart Failure, Preserved... | 540 | Hungary, Italy, Poland, United States | clinicaltrials.gov |
| November 6, 2026 | NCT07920874 | Financial Tools Access and Navigation (FinTAN) | Yale University | Not applicable | Not yet recruiting | Serious Mental Illness, Financial Hardship | 60 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07920497 | Weighted Blankets for Agitation in Adults in the Intensive Care Unit | Anmed Health | Not applicable | Active not recruiting | Psychomotor Agitation, Critical Illness | 200 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07920484 | A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral... | Amber Implants B.V. | Observational | Recruiting | Vertebra Compression Fracture | 30 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07920341 | Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes | University of the Pacific | Not applicable | Not yet recruiting | Continuous Glucose Monitoring, Type 1 Diabetes, Type 2 Diabetes | 60 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07920185 | A Study of Oral SOM001 as a Safe and Effective Treatment for Adults With Chronic Insomnia in a Randomized, Controlled, Dose-finding Study | Somnum Pharma Inc. | Phase 2 | Not yet recruiting | Chronic Insomnia | 45 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07920081 | Psilocybin for Amblyopia - Targeting Critical Periods in Humans | Johns Hopkins University | Phase 1/2 | Recruiting | Amblyopia | 24 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919847 | Universal Screening for Blunt Cerebrovascular Injury | Inova Health Care Services | Not applicable | Not yet recruiting | Cerebrovascular Trauma | 5,000 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919821 | Early Feeding TL Trial | University of Florida | Phase 2 | Not yet recruiting | Total Laryngectomy | 120 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919782 | Study to Evaluate Xtressé Gummy Supplement in Women With Thinning Hair | Restore Biologics Holdings, Inc. dba Xtressé | Not applicable | Not yet recruiting | Androgenetic Alopecia | 30 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | Canada, United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919509 | A Project Assessing the Safety and Feasibility of Using Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Ovarian Cancer During... | University of Alabama at Birmingham | Phase 1 | Not yet recruiting | Cancer, Chemotherapy, Squamous Cell Carcinoma (SCC) | 6 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919483 | Daily Stretching to Improve Walking in Older Patients With Peripheral Artery Disease: The STRETCH PAD Study | Penn State University | Not applicable | Not yet recruiting | Peripheral Artery Disease (PAD), Intermittent Claudication | 300 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany... | clinicaltrials.gov |
| November 5, 2026 | NCT07919392 | Restoring Emotional Needs With Exogenous Ketones for Women With Postpartum Depression | Ohio State University | Not applicable | Recruiting | Postpartum Depression (PPD) | 40 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07919353 | Penn Family Screening for Familial Hypercholesterolemia (NHLBI R33) Trial 3 | Northwestern University | Not applicable | Not yet recruiting | Familial Hypercholesterolemia | 110 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918989 | A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After... | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Breast Cancer, Breast Cancer Female | 138 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918963 | Pilot of a Drug Education Curriculum for Middle and High School Students | Massachusetts General Hospital | Not applicable | Completed | Substance Use (Drugs, Alcohol), Health Risk Behaviors, Youth, Adolescent Behavior | 48 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918859 | A Study of Imlunestrant (LY3484356) in Healthy Female Participants | Eli Lilly and Company | Phase 1 | Not yet recruiting | Healthy | 343 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918768 | Restoring Speech With an Intracortical Neuroprosthesis for Post-Stroke Agrammatic Aphasia (BG-Aphasia-02) | Leigh R. Hochberg, MD, PhD. | Not applicable | Not yet recruiting | Aphasia, ALS, Stroke | 2 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918508 | Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health | Florida International University | Not applicable | Not yet recruiting | Hypertension (HTN), CKD - Chronic Kidney Disease, Cardio-Renal Syndrome, Food Insecurity, Type 2 Diabetes | 200 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918261 | Evaluation of Fisetin to Reduce Systemic Senescence | Steadman Philippon Research Institute | Phase 1/2 | Completed | Cellular Senescence | 82 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07918196 | Postprandial Glycemic and GLP-1 Responses to Modified Full-sugar Drinks | Purdue University | Not applicable | Active not recruiting | Postprandial Glucose, GLP-1 Concentration, Satiety | 16 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07917845 | Evaluation of Massage Therapy for Cancer Related Fatigue in Breast Cancer Survivors | Wake Forest University Health Sciences | Not applicable | Not yet recruiting | Breast Cancer, Fatigue in Cancer Survivors | 34 | United States | clinicaltrials.gov |
| November 5, 2026 | NCT07917832 | Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large... | M.D. Anderson Cancer Center | Phase 2 | Not yet recruiting | Multi Center, Phase 2, Golcadomide, Glofitamab, Polauzumab, Vedotin, G2p, B Cell Lymphoma | 60 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07917728 | Smartphone Enabled Detection of Cognitive Motor Dissociation in the ICU | Columbia University | Observational | Recruiting | Traumatic Brain Injury (TBI) Patients, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Cardiac Arrest (CA) | 240 | Brazil, Canada, Colombia, Japan, United States | clinicaltrials.gov |
| November 4, 2026 | NCT07917598 | TEA Synchronized With Natural Breathing for EPS | MetroHealth Medical Center | Phase 1 | Not yet recruiting | Epigastric Pain Syndrome | 40 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07917403 | Study NRPT Feasibility in Knee Osteoarthritis | University of California, San Diego | Not applicable | Recruiting | Knee Osteoarthristis | 30 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07917221 | Proof-of-concept for Use of Transcutaneous Spinal Stimulation (TSS) With the ExaStim® Stimulation System in Adults With Chronic Ischemic... | Casa Colina Hospital and Centers for Healthcare | Not applicable | Not yet recruiting | Chronic Stroke, Ischemic Stroke, CVA (Cerebrovascular Accident) | 5 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07917208 | Early Feasibility Study of the Capstan Medical TMVR System | Capstan Medical | Not applicable | Recruiting | Mitral Regurgitation (MR) | 15 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07917013 | Hangeoreum: A Self-Paced Web-Based Program for Loneliness and Connectedness Among Korean Immigrants Aged 50 and Older | University of South Florida | Not applicable | Not yet recruiting | Loneliness, Korean, Older Adults (50-94 Years), Immigrant | 40 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07916974 | Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID) | Yale University | Not applicable | Not yet recruiting | Anxiety Disorder of Adolescence, Avoidant / Restrictive Food Intake Disorder | 110 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07916883 | PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite) | Washington University School of Medicine | Observational | Not yet recruiting | Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic, Asymptomatic Carotid Artery Stenosis | 30 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07916818 | High-Tech, High-Touch | Touro University, California | Not applicable | Completed | Stress (Psychology), Resilience, Psychological, Anxiety, Depressive Symptoms, Well-being, Sleep Quality | 43 | United States | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Mayo Clinic | 350 | November 9, 2026 |
| M.D. Anderson Cancer Center | 229 | November 5, 2026 |
| Massachusetts General Hospital | 214 | November 9, 2026 |
| University of California, San Francisco | 201 | November 2, 2026 |
| Stanford University | 193 | November 4, 2026 |
| Washington University School of Medicine | 163 | November 9, 2026 |
| Yale University | 162 | November 6, 2026 |
| VA Office of Research and Development | 162 | October 29, 2026 |
| Eli Lilly and Company | 158 | November 6, 2026 |
| Merck Sharp & Dohme LLC | 154 | October 15, 2026 |
| NYU Langone Health | 152 | November 4, 2026 |
| AstraZeneca | 152 | October 1, 2026 |
| Memorial Sloan Kettering Cancer Center | 149 | November 5, 2026 |
| Pfizer | 143 | November 9, 2026 |
| University of Michigan | 142 | November 6, 2026 |
| Duke University | 141 | November 2, 2026 |
| University of Alabama at Birmingham | 137 | November 9, 2026 |
| University of Pennsylvania | 133 | November 4, 2026 |
| Novartis Pharmaceuticals | 133 | November 2, 2026 |
| Brigham and Women's Hospital | 129 | November 6, 2026 |
Conditions
| Condition group | New trials | Latest |
|---|---|---|
| Obesity | 566 | November 9, 2026 |
| Neoplasms | 427 | November 9, 2026 |
| Breast Neoplasms | 389 | November 5, 2026 |
| Depression | 348 | November 9, 2026 |
| Overweight | 348 | November 9, 2026 |
| Motor Activity | 337 | November 4, 2026 |
| Anxiety Disorders | 300 | November 9, 2026 |
| Diabetes Mellitus, Type 2 | 288 | November 9, 2026 |
| Prostatic Neoplasms | 283 | November 9, 2026 |
| Carcinoma, Non-Small-Cell Lung | 260 | November 3, 2026 |
| Colorectal Neoplasms | 233 | November 3, 2026 |
| Pain | 198 | October 29, 2026 |
| Lung Neoplasms | 195 | November 2, 2026 |
| Stroke | 194 | November 6, 2026 |
| Hypertension | 189 | November 5, 2026 |
| Diabetes Mellitus | 181 | November 4, 2026 |
| Cognitive Dysfunction | 181 | November 3, 2026 |
| Alzheimer Disease | 178 | October 20, 2026 |
| Psychological Well-Being | 177 | November 6, 2026 |
| Stress Disorders, Post-Traumatic | 174 | October 29, 2026 |
| Heart Failure | 172 | November 3, 2026 |
| Substance-Related Disorders | 167 | November 5, 2026 |
| Parkinson Disease | 162 | November 6, 2026 |
| Chronic Pain | 160 | November 4, 2026 |
| Opioid-Related Disorders | 160 | October 28, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 8,337 | November 9, 2026 |
| Observational | 2,605 | November 9, 2026 |
| Phase 2 | 2,201 | November 9, 2026 |
| Phase 1 | 1,928 | November 9, 2026 |
| Phase 3 | 1,165 | November 9, 2026 |
| Phase 4 | 775 | November 9, 2026 |
| Phase 1/2 | 721 | November 9, 2026 |
| Early phase 1 | 342 | November 2, 2026 |
| Phase 2/3 | 168 | November 6, 2026 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.